Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
about
Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryAnthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesHigh throughput physiological screening of iPSC-derived cardiomyocytes for drug development.Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.Alternative Biomarkers for Combined Biology.Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes."Watching the Detectives" report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015.Highlight report: Cardiotoxicity screening.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.Translational systems pharmacology-based predictive assessment of drug-induced cardiomyopathy.[Leukocyte count of puerperal sows].Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
P2860
Q28072402-21FB063A-3A1E-4A51-AA40-D11AA6B8A980Q33658456-8027F3D1-4899-4068-98CA-C1B0C5863620Q36864827-7941579D-1262-4403-8A8F-7E73A22BBFBAQ36948480-5B7B2F69-E74D-4264-8E2B-003315069270Q37704467-C16C2C0D-2CCD-4C7D-908F-4FF3DA713283Q38747992-D38081DC-3263-4DC8-BFCF-E3012C629309Q38831212-4C3FF03F-5E19-44FD-8963-75F470F71111Q38873791-08250D39-6BA7-4790-B5CF-AB58A6270C73Q39777153-51DBEC88-719B-4F02-9A32-3D462CAB98BDQ40026732-D223C98D-4CA7-4F38-A8A0-04506FBBB770Q48353831-08ED9797-C27C-4E97-A86F-C7442175FB08Q49350716-B1E3EE5E-4A8D-4C24-BF2F-4FEEF46E3E3CQ49907223-B0F9E733-24E4-4B8F-A977-BE5262004D9CQ50006311-FA262C78-0F40-4DF3-97F8-ECD08FD3D8C0Q50300835-85DB060C-4296-4700-A9C3-2503510D7336Q57490090-10E9EDB9-DD7F-4617-BAC4-333A300A703F
P2860
Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of genomic biom ...... pproach for safety assessment.
@en
type
label
Identification of genomic biom ...... pproach for safety assessment.
@en
prefLabel
Identification of genomic biom ...... pproach for safety assessment.
@en
P2093
P2860
P1476
Identification of genomic biom ...... pproach for safety assessment.
@en
P2093
Dimitry Spitkovski
Filomain Nguemo
Harshal Nemade
Hector C Keun
James K Ellis
Jan G Hengstler
Jochem Louisse
John Antonydas Gaspar
Sureshkumar Perumal Srinivasan
Susanne Bremer
P2860
P2888
P304
P356
10.1007/S00204-015-1623-5
P577
2015-11-04T00:00:00Z